Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tetratricopeptide repeat domain 34 (TTC34) is a protein encoded by the TTC34 gene in humans and is a member of the tetratricopeptide repeat domain-containing protein family[3][6]. These proteins are characterized by the presence of multiple tetratricopeptide repeat (TPR) motifs, each consisting of a degenerate 34-amino acid sequence. TPR motifs facilitate protein–protein interactions by forming alpha-helical scaffolds that usually mediate the assembly of multiprotein complexes[1][5]. TTC34’s precise physiological functions remain uncharacterized, and there is little experimental data confirming a distinct role in human biology or disease. Based on gene expression studies, it appears to be broadly expressed in various tissues, but there is no evidence to support its specific involvement as a drug target, biomarker, or significant disease gene. Most knowledge about TTC34 is based on bioinformatic prediction of domain architecture and homology to other TPR-containing proteins[1][3][6].
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetratricopeptide repeat domain 34 (TTC34).